ClinicalTrials.Veeva

Menu

Evaluation of a Dry Powder Aerosol Dispersion Mechanism by Radiolabeling Techniques (DPI)

University of North Carolina (UNC) logo

University of North Carolina (UNC)

Status

Completed

Conditions

Adult Healthy Volunteers

Treatments

Device: modified Handihaler DPI
Device: standard Handihaler DPI

Study type

Interventional

Funder types

Other

Identifiers

NCT01495442
11-1260

Details and patient eligibility

About

The primary objective is to admix a radiolabel with albuterol sulphate for incorporation into the Handihaler® device for inhalation studies. This will allow for the investigators to determine the regional lung deposition of drug inhaled from the standard Handihaler® device compared to a novel modification of the device to provide more effective dispersion and aerosolization of the coated albuterol powder. The new mechanism of action for proof-of-concept testing consists of a bead (5.1 mm; expanded polystyrene foam) coated with drug powder, as opposed to the standard lactose formulation-filled capsule.

Enrollment

6 patients

Sex

All

Ages

18 to 50 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • healthy volunteers adults

Exclusion criteria

  • chronic illness

Trial design

Primary purpose

Basic Science

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Single Blind

6 participants in 2 patient groups, including a placebo group

modified Handihaler DPI
Active Comparator group
Treatment:
Device: modified Handihaler DPI
standard Handihaler DPI
Placebo Comparator group
Treatment:
Device: standard Handihaler DPI

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems